| Entry |
|
|---|
| Name |
Tezacitabine (USAN);
Tezacitabine monohydrate |
|---|
| Formula |
C10H12FN3O4. H2O
|
|---|
| Exact mass |
275.0917
|
|---|
| Mol weight |
275.23
|
|---|
| Structure |
|
|---|
| Simcomp |
|
|---|
| Class |
Antineoplastic
DG02018 Antimetabolite
DG01958 Nucleic acid derivative, antineoplastic
DG01439 Arabinofuranosyl type antineoplastic
|
|---|
| Efficacy |
Antineoplastic, Antimetabolite |
|---|
| Target |
|
|---|
| Pathway |
|
|---|
| Interaction |
|
|---|
| Brite |
Drug groups [BR:br08330]
Antineoplastic
DG02018 Antimetabolite
DG01958 Nucleic acid derivative, antineoplastic
DG01439 Arabinofuranosyl type antineoplastic
D06100 Tezacitabine
Target-based classification of drugs [BR:br08310]
Enzymes
Oxidoreductases (EC1)
Ribonucleoside-diphosphate reductase
RRM1
D06100 Tezacitabine (USAN)
|
|---|
| Other DBs |
|
|---|
| LinkDB |
|
|---|
| KCF data |
ATOM 19
1 C1y C 31.3641 -16.6552
2 O2x O 30.2453 -15.8508
3 C1y C 29.0727 -16.6787
4 C1y C 29.5154 -17.9855
5 C2y C 30.9422 -17.9965
6 C2b C 31.7699 -19.1691
7 X F 31.2253 -20.4134
8 O1a O 28.7110 -19.1043
9 N5x N 35.1128 -16.1543
10 C8y C 35.1465 -14.7557
11 C8x C 33.9395 -14.0871
12 C8x C 32.6989 -14.8190
13 N4y N 32.6709 -16.2126
14 C8y C 33.9419 -16.8844
15 O5x O 33.9782 -18.2831
16 N1a N 36.3173 -14.0256
17 C1b C 27.7314 -16.2568
18 O1a O 26.6816 -17.1816
19 O0 O 36.4479 -19.7258
BOND 19
1 1 2 1
2 2 3 1
3 3 4 1
4 4 5 1
5 1 5 1
6 5 6 2
7 6 7 1
8 4 8 1 #Down
9 9 10 2
10 10 11 1
11 11 12 2
12 12 13 1
13 13 14 1
14 9 14 1
15 14 15 2
16 10 16 1
17 1 13 1 #Up
18 3 17 1 #Up
19 17 18 1
|
|---|
